S. Vaidya et al., CLINICAL IMPORTANCE OF PRE-MORTEUM BLOOD-LYMPHOCYTES IN CADAVER DONORTISSUE TYPING, Clinical transplantation, 9(3), 1995, pp. 165-170
We have refined our immunomagnetic bead (IM bead) procedures to isolat
e pure and viable lymphocyte subpopulation from premorteum (PM) blood
for cadaver donor HLA typing, preliminary and final crossmatches (XMs)
. The results of 1220 XMs were compared using T/B lymphocytes isolated
either from PM blood or spleen/lymphnode (SPLN) tissue. IM bead techn
ique was used to isolate T/B cells from PM blood and nylon wool column
(NWC) techique was used to isolate T/B cells from SPLN. When we compa
red the outcome of 800 T-cell crossmatches using T cells from PM blood
or SPLN of 5 separate cadaver donors, NWC TXMs tended to be more fals
enegative for high PRA (>10%, total 500 XMs), as well as low PRA (<10%
, total 300 XMs) did not reach statistical significance. In contrast,
NW BXM (420 B XM) were found to be far more false negative than IM bea
d BXM regardless of the PRA of the patients. In order to ensure that N
WC BXMs were indeed false negative, 23 sera with known anti-DR antibod
ies were BXMed where antigen-specific B cells were isolated by both th
e techniques. Our results showed that IM bead BXM identified the DR sp
ecificities greater than 90% of the time, the titers of ab specificiti
es were stronger (1:8). In comparison, NWB cell XMs were weak (titers
1:2), and the false negative rate for some ab was as high as 73%. Usin
g IM bead and NWC techniques we compared our turnaround time (TAT) for
cadaver donor typing, preliminary and final XMs. Using PM blood with
IM bead, our TAT was less than 5 hours for the entire cadaver donor wo
rk-up. In contrast, TAT from SPLN with NWC technique was as long as 8
hours. We also compared graft survival statistics of 153 patients tran
splanted on a basis of negative T/BXM using either PM blood lymphocyte
s (98 patients) or SPLN lymphocytes (55 patients). However, lymphocyte
s in either case were isolated by IM bead assay We found no adverse ou
tcome due to usage of PM blood lymphocytes in terms of long- or short-
term graft survival or incidence of hyperacute rejection. In fact, col
d ischemia time (CIT) was much shorter (median 12 hours) in the PM gro
up versus more than 20 hours in SPLN group. In summary, PM blood is an
ideal source of T/B lymphocytes for the solid organ pretransplant wor
kup and final XM.